Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial

por Samtsov, Alexey V., Bakulev, Andrey L., Khairutdinov, Vladislav R., Kokhan, Muza M., Korotaeva, Tat’yana V., Minullin, Iskander K., Vylegzhanina, Olga A., Dubenskiy, Valery V., Khalilov, Bulat V., Khotko, Alkes A., Zykova, Olga S., Chumachenko, Irina V., Lukyanov, Alexander M., Artemeva, Antonina V., Pukhtinskaia, Polina P.
Publicado 2022

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled pha...

por Lomakin, Nikita V., Bakirov, Bulat A., Protsenko, Denis N., Mazurov, Vadim I., Musaev, Gaziyavdibir H., Moiseeva, Olga M., Pasechnik, Elena S., Popov, Vladimir V., Smolyarchuk, Elena A., Gordeev, Ivan G., Gilyarov, Mikhail Yu, Fomina, Darya S., Seleznev, Anton I., Linkova, Yulia N., Dokukina, Ekaterina A., Eremeeva, Anna V., Pukhtinskaia, Polina S., Morozova, Maria A., Zinkina-Orikhan, Arina V., Lutckii, Anton A.
Publicado 2021